Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
De novo design of a nanoregulator for the dynamic restoration of ovarian tissue in cryopreservation and transplantation.
Jiang M, Zhang GH, Yu Y, Zhao YH, Liu J, Zeng Q, Feng MY, Ye F, Xiong DS, Wang L, Zhang YN, Yu L, Wei JJ, He LB, Zhi W, Du XR, Li NJ, Han CL, Yan HQ, Zhou ZT, Miao YB, Wang W, Liu WX. Jiang M, et al. Among authors: han cl. J Nanobiotechnology. 2024 Jun 11;22(1):330. doi: 10.1186/s12951-024-02602-5. J Nanobiotechnology. 2024. PMID: 38862987 Free PMC article. Review.
Role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta-analysis.
Cao QH, Liu H, Yan LJ, Wang HC, Ding ZN, Mao XC, Li RZ, Pan GQ, Zhang X, Tian BW, Han CL, Dong ZR, Tan SY, Wang DX, Yan YC, Li T. Cao QH, et al. Among authors: han cl. J Gastroenterol Hepatol. 2024 Aug;39(8):1464-1475. doi: 10.1111/jgh.16558. Epub 2024 Apr 30. J Gastroenterol Hepatol. 2024. PMID: 38686439
The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Han CL, Tian BW, Yan LJ, Ding ZN, Liu H, Pan GQ, Zhang X, Mao XC, Tan SY, Li RZ, Wang DX, Dong ZR, Yan YC, Li T. Han CL, et al. Expert Rev Anticancer Ther. 2024 May;24(5):303-312. doi: 10.1080/14737140.2024.2341723. Epub 2024 Apr 16. Expert Rev Anticancer Ther. 2024. PMID: 38623811 Review.
Inflammation, infection, and cardiovascular risk.
Lin GM, Huang WC, Han CL. Lin GM, et al. Among authors: han cl. Lancet. 2024 Mar 16;403(10431):1021-1022. doi: 10.1016/S0140-6736(23)02872-6. Lancet. 2024. PMID: 38492934 No abstract available.
231 results